Showing results (161-170 of 299) with videos related to
Sort By:
Pageof 30
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2003
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group studyDavid W Haas, Hulin Wu, Haihong Li, et al.Open Forum Infectious Diseases|August 28, 2023
Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular DiseaseMichael L Freeman, Mian B Hossain, Shana A B Burrowes, et al.Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 17, 2005
New entrants to HIV care are presenting only at marginally earlier stages of disease but may increasingly represent groups perceived at lower riskChariclia V Loupa, Michael M Lederman, Hernán Valdez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2018
Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral SuppressionMartin Hoenigl, Carlee B Moser, Nicholas Funderburg, et al.Open Forum Infectious Diseases|March 2, 2023
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare WorkersMichael L Freeman, Oladayo A Oyebanji, Daniela Moisi, et al.Frontiers in Immunology|September 13, 2024
Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllersEva Poveda, Wendy Fitzgerald, Jacobo Alonso-Domínguez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaborationDavid W Haas, John A Bartlett, Janet W Andersen, et al.Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.The Journal of Infectious Diseases|February 13, 2008
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patientsJacob Lalezari, Gopal K Yadavalli, Michael Para, et al.Journal of Virus Eradication|March 10, 2017
Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patientsMaura Manion, Bruno B Andrade, Rebecca DerSimonian, et al.Pageof 30